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BACKGROUND: A significant proportion of US Latinos
with diabetes have limited English proficiency (LEP).
Whether language barriers in health care contribute to
poor glycemic control is unknown.
OBJECTIVE: To assess the association between limited
English proficiency (LEP) and glycemic control and
whether this association is modified by having a
language-concordant physician.
DESIGN: Cross-sectional,observationalstudyusingdata
from the 2005–2006 Diabetes Study of Northern
California (DISTANCE). Patients received care in a
managed care setting with interpreter services and
self-reported their English language ability and the
Spanish language ability of their physician. Outcome was
poor glycemic control (glycosylated hemoglobin A1c>9%).
KEY RESULTS: The unadjusted percentage of patients
with poor glycemic control was similar among Latino
patients with LEP (n=510) and Latino English-speakers
(n=2,683), and higher in both groups than in whites
(n=3,545) (21% vs 18% vs. 10%, p<0.005). This
relationship differed significantly by patient-provider
language concordance (p<0.01 for interaction). LEP
patients with language-discordant physicians (n=115)
were more likely than LEP patients with language-
concordant physicians (n=137) to have poor glycemic
control (27.8% vs 16.1% p=0.02). After controlling for
potential demographic and clinical confounders, LEP
Latinos with language-concordant physicians had sim-
ilar odds of poor glycemic control as Latino English
speakers (OR 0.89; CI 0.53–1.49), whereas LEP Latinos
with language-discordant physicians had greater odds
ofpoorcontrolthanLatinoEnglishspeakers(OR 1.76; CI
1.04–2.97). Among LEP Latinos, having a language
discordant physician was associated with significantly
poorer glycemic control (OR 1.98; CI 1.03–3.80).
CONCLUSIONS: Language barriers contribute to health
disparities among Latinos with diabetes. Limited
English proficiency is an independent predictor for poor
glycemic control among insured US Latinos with diabetes,
an association not observed when care is provided by
language-concordant physicians. Future research should
determine if strategies to increase language-concordant
careimproveglycemiccontrolamongUSLatinoswithLEP.
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INTRODUCTION
Population-based studies in the United States report that
Latinos are disproportionately affected by diabetes, tend to
have worse glycemic control, and suffer more diabetes-related
complications than their white, non-Latino counterparts.
1–4
Recent studies suggest that disparities in glycemic control
between whites and Latinos may be increasing.
5,6
Many social factors contribute to poor glycemic control
among Latinos. Compared to other major population groups
in the US, Latinos are the most likely to be uninsured
7 and are
more likely to report financial barriers to medication use.
8
Latinos are also more likely than other groups to report limited
English proficiency(LEP), and the proportion of Latinos withLEP
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170has increased in recent years: 39% of Latinos in the US reported
speaking English less than “very well” in 2004.
9 While research
involving diverse populations with diabetes has shown robust
relationshipsbetweenpatient-physiciancommunication,patient
satisfaction, and health-promoting behaviors,
10–12 it remains
unclear whether language barriers render health care less
effective for Latinos with diabetes and LEP or contribute to
known disparities in care. The few studies that have directly
examinedtheassociationbetweenpatientlanguageandglycemic
control have each concluded that language barriers are not
associated with glycemic control, although these study findings
may have been limited by small sample size
13 or lack of detailed
clinical and demographic data,
1,14 or influenced by a high degree
of physician-patient language concordance.
1,15
We employed data from a well-characterized cohort of
insured patients with diabetes to determine (1) whether LEP
was associated with poor glycemic control among Latinos and
(2) whether having a language-concordant physician was
associatedwithbetterglycemiccontrolamongLatinoswithLEP.
METHODS
The Diabetes Study of Northern California (DISTANCE) sur-
veyed a race-stratified random sample of members of the
Kaiser Permanente Northern California (KPNC) Diabetes Reg-
istry.
16 The DISTANCE survey assessed a range of social,
behavioral, and care-related factors that might influence
diabetes outcomes. Surveys were offered in five languages
(including English and Spanish) and could be completed via
mail, on the web, or by phone. The survey was in the field
during 2005–2006 and had a response rate of 62%.
16
DISTANCE was approved by the institutional review boards
of the Kaiser Foundation Research Institute and the University
of California, San Francisco School of Medicine.
Study Setting
KPNC is a nonprofit, integrated health care delivery system
providing comprehensive medical care to a diverse population
of approximately 3.2 million members in Northern California.
Distribution of patient demographic and socioeconomic factors
is similar to that of the area population, except in the extremes
of the income distribution.
17 Each KPNC facility provides
bilingual clinicians and interpreter services offered through
qualified bilingual staff, telephone language interpreters, and
on-site professional interpreters for their patients with LEP.
Study Participants
Among the ∼20,000 DISTANCE respondents, there were 8,397
whose primary race/ethnic self-identification was Latino
(3,877) or white (4,520). We excluded subjects who had an
enrollment gap in the health plan of greater than 30 days in
the year prior to the survey (n=167), did not have at least one
glycosylated hemoglobin A1c (A1c) measure in the year prior to
t h es u r v e y( n = 9 2 9 ) ,o rw e r ei d e n t i f i e da sh a v i n gt y p e1
diabetes (n=384). We also excluded those who did not respond
to the survey question regarding their own English language
proficiency (n=42) and, among whites, excluded those report-
ing difficulty with English (n=47). For modeling purposes,
those without an assigned primary care physician (PCP) or
medical care facility were excluded (n=88), leaving 6,738
respondents who formed the basis for the following analysis.
Study Measures
English proficiency was assessed by asking, “How often do you
have difficulty understanding or speaking English?” Those
who responded “usually” or “often” were considered to have
LEP, while those who responded “sometimes,”“ rarely,” or
“never” were designated as English-speaking. This item was
modeled after the item used by the US Census and in other
studies of LEP patients.
18,19 Physician language concordance
was assessed by asking the participants, “Without using an
interpreter, how well does your personal physician speak your
language?” LEP participants who responded “well,”“ very well,”
or “excellent” were considered to have a language-concordant
primary care physician (LEP-concordant), whereas those who
responded “fair,”“ poorly,” or “does not speak my language”
were considered to have a language-discordant physician
(LEP-discordant). LEP patients who did not respond to the
question on physician language proficiency were designated as
“LEP-missing.”
Demographic information and time since diabetes diagnosis
were determined from patient survey responses. KPNC data
from 2005 were used to generate individual comorbidity scores
using the DXCG, a validated risk assessment tool designed to
quantify a patient’s illness burden.
20 Patients whose benefit
records showed no gap of greater than 30 days in pharmacy
coverage during the year prior to the survey response date
were categorized as having continuous pharmacy benefits.
Outcome Measures
We used the last A1c test obtained in the year prior to
completion of the questionnaire to create our main outcome
measure. This laboratory result was obtained during routine
clinical care. Following national guidelines, we defined poor
glycemic control to be A1c>9%.
21
Statistical Analysis
We compared characteristics of white, Latino-English-speakers
and Latino patients with LEP using chi-squared tests for
categorical variables and Student’s t-tests for continuous vari-
ables. Among Latino patients with LEP, we compared the LEP-
discordant and the LEP-missing groups to the LEP-concordant
group. We then compared the odds of poor glycemic control (A1c
>9%) between white, Latino English-speakers and Latino
patients with LEP using generalized estimating equations
(GEE) models to account for clustering of patients by physician
and healthcare facility. We also specified models that included
an interaction term for patient-provider language concordance ×
LEP status to evaluate whether the LEP-A1c relationship
differed by patient-provider concordance. Finding this interac-
tion to be significant (p<0.01 for interaction term), we ran
subsequent adjusted analyses stratified by patient-provider
language concordance and LEP status. The following groups of
covariates were added sequentially to adjusted models: demo-
171 Fernandez et al.: Language Barriers and Glycemic Control JGIMgraphic variables (age, sex); SES (income, education); clinical
characteristics (diabetes duration and co-morbidity index); and
pharmacy benefits. If an individual term did not substantively
alter the point estimate of the main effect, it was not considered
confounding and was eliminated from the final model. We
included missing indicatorsfor all variablesthat were incomplete
in all our models. We repeated all analyses with mean A1c as the
outcome using linear GEE models. Finally, we used the Least
Square Means option in SAS (SAS 9.1) to generate predicted
probabilities of poor control and mean A1c by exposure group.
In order to determine if our results were sensitive to our
definition of LEP, we repeated our analyses including patients
who reported “sometimes” having difficulty with English in the
LEP group.
RESULTS
The study population of 6,738 included 3,545 white patients,
2,683 English-speaking Latino patients, and 510 Latino
patients with LEP. Patients were seen at 48 facilities, with no
single facility contributing more than 10% of patients with
LEP. Latino patients were cared for by 988 PCPs, of whom 296
had at least 1 study patient with LEP. The majority (90%) of the
patients with LEP were cared for by a physician who had 3 or
fewer study LEP patients (range 1–13).
White, Latino English-speakers, and Latino patients with
LEP differed in several ways (Table 1). Whites were more likely
than either of the Latino groups to be male and report more
education and greater income. English-speaking Latino
patients were more likely than their LEP counterparts to be
male (50.1% vs 36.1%), have finished high school (69.5% vs
29.0%), have annual incomes of $35,000 or above (56.1% vs
23.3%), and have continuous pharmacy benefits during the
year prior to the survey (94.4% vs 85.9%) (P value for all
comparisons<0.001). Mean co-morbidity index values were
similar in the two Latino groups and slightly lower than the
white group.
Characteristics of the 510 patients within the three LEP
groups differed only slightly. LEP-discordant patients (n=115)
were marginally less likely than LEP-concordant patients (n=
137) to report an annual income under $35,000 (58.3% vs
64.2%, p=0.08) and marginally more likely to have continuous
pharmacy benefits (90.4% vs 82.5%, p=0.07). LEP-missing
were less likely than LEP-concordant participants to provide
income information (8.8% vs 24.0%, p<0.05).
Overall, the unadjusted percentage of patients with poor
glycemic control was similar among Latino patients with LEP
and Latino English-speakers and higher in both groups than
in whites (21% vs 18% vs 10%, respectively, p<0.05 for each
white vs Latino comparison); mean A1c had a similar pattern
(7.8 vs 7.6 vs 7.2, p<0.05) (Table 1). However, LEP-discordant
patients were more likely than LEP-concordant patients to
have poor glycemic control (27.8% vs 16.1%, p=0.02) and to
have somewhat higher mean A1c values (8.0 vs 7.6, p=0.07).
Accounting for clustering by physician and care facility
changed the univariate patterns somewhat; LEP Latino
patients were more likely to be in poor glycemic control (A1c
>9%) than English-speaking Latinos (OR 1.24; CI 1.01–1.52)
(Table 2). In stratified models, LEP-concordant patients were no
more likely than Latino English-speakers to have poor control
(OR 0.87; 95% CI 0.53–1.43). In contrast, LEP-discordant
patients were significantly more likely to be in poor control than
Latino English-speakers (OR 1.76; 95% CI 1.06–2.93). LEP-
missing had odds of poor control intermediate between those of
the other two LEP groups (OR 1.23; 95% CI 0.89–1.71).
Adjustment for covariates made minimal difference in the
odds of poor control when comparing whites to Latino English
speakers (OR 1.67; CI 1.44–1.95) or when comparing LEP
groups to Latino English-speakers (Table 2). Final model
covariates included age, sex, co-morbidity index score, time
since diabetes diagnosis, and pharmacy benefits. Income and
education had no significant impact on point estimates, so
Table 1. Characteristics of 6,738 Insured Patients with Diabetes by Ethnicity, English Language Proficiency, and Physician Language
Concordance
Whites
(n=3,545)
English Latinos
(n=2,683)
LEP Latinos
(n=510)
LEP-Concordant PCP
(n=137)
LEP-Discordant PCP
(n=115)
LEP-Missing
(n=258)
Age, mean (SD) 60.6 (9.4) 57.3 (10.8)
a 56.9 (10.8) 57.5 (11.5) 56.0 (10.5) 56.9 (10.5)
Men, n (%) 1,987 (56.1) 1,345 (50.1)
a 184 (36.1)
b 52 (38.0) 38 (33.0) 94 (36.4)
Education, n (%)
Less than high school 390 (11.0) 741 (27.6)
a 356 (69.8)
b 100 (73.0) 81 (70.4) 175 (67.8)
d
High school or above 3,121 (88.0) 1,864 (69.5) 148 (29.0) 33 (24.1) 32 (27.8) 83 (32.1)
Missing 34 (1.0) 78 (2.9) 6 (1.2) 4 (2.9) 2 (1.7) 0
Annual household income, n (%)
0–$34,999 831 (23.4) 898 (33.5)
a 296 (58.0)
b 88 (64.2) 67 (58.3) 141 (54.7)
d
≥$35,000 2,336 (65.9) 1,505 (56.1) 119 (23.3) 37 (27.0) 27 (23.5) 55 (21.3)
Missing 378 (10.7) 280 (10.4) 95 (18.6) 12 (8.8) 21 (18.3) 62 (24.0)
Years since DM diagnosis, mean (SD) 8.9 (8.0) 9.5 (8.2)
a 9.5 (8.5) 9.8 (8.3) 10.1 (10.1) 9.1 (7.9)
Comorbidity score, mean (SD) 4.76 (4.9) 4.4 (4.7)
a 4.0 (4.2) 3.7 (3.4) 4.3 (5.2) 4.0 (4.2)
Continuous pharmacy benefits, n (%) 3,477 (98.1) 2,533 (94.4)
a 438 (85.9)
b 113 (82.5) 104 (90.4) 221 (85.7)
HbA1c>9%, n (%) 353 (10.0) 484 (18.0)
a 109 (21.4) 22 (16.1) 32 (27.8)
c 55 (21.3)
HbA1c, mean (SD) 7.2 (1.4) 7.6 (1.7)
a 7.8 (1.8) 7.6 (1.6) 8.0 (1.9) 7.9 (1.9)
Abbreviations: English Latinos: English-speaking Latinos; LEP: limited English proficient; LEP with language-concordant PCP; LEP with language-
discordant PCP; LEP-Missing: LEP without physician language data
aWhites vs. English-speaking Latinos: p value<0.05
bEnglish-speaking Latinos vs. LEP Latinos: p value<0.05
cLEP-Concordant vs. LEP-Discordant: p value<0.05
dLEP-Missing vs. LEP-Concordant: p value<0.05
Totals may not add to 100% due to rounding
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comparison between the LEP groups revealed that LEP-
discordant patients had two-fold greater odds of poor glycemic
control compared to LEP-concordant patients (OR 1.98; CI
1.03-3.80). After setting demographic and clinical covariates to
the study population mean for each group, the predicted
probability of poor glycemic control among LEP-discordant
patients was 20.9% (CI: 13.0, 31.9) compared to 11.8% (CI:
7.3, 18.4) among LEP-concordant patients.
Analysis of the association of Latino patient English profi-
ciency and physician language concordance with A1c as a
continuous outcome in GEE linear models yielded similar
relationships. The LEP-concordance interaction term was sig-
nificant (p=0.03), and adjusted models comparing the least
mean squares A1c between English-speaking and LEP-concor-
dant groups showed no significant difference (7.64 vs 7.58, p=
0.72). Differences in mean A1c between English-speaking and
LEP-discordant groups did not reach statistical significance in
adjusted models (7.64 vs 7.94, p=0.18). In a sensitivity analysis
including patients who reported “sometimes” having trouble
speaking English within the LEP group, the results of the final
models were qualitatively similar but with broader, non-signif-
icant confidence intervals (data not shown). Repeating all
analyses using logistic regression without accounting for
clustering yielded nearly identical results (data not shown).
DISCUSSION
In a study of patients with diabetes in a managed care setting
with interpreter services, we found that Latino patients with
limited English proficiency were somewhat more likely than
English-speaking Latinos to have poor glycemic control (A1c>
9.0%). However, the association between LEP and glycemic
control was strongly modified by physician-patient language
concordance. LEP patients with language-concordant physi-
cians were no more likely to have poor glycemic control than
Latino English-speaking patients; in contrast, LEP patients
with language-discordant physicians were significantly more
likely to have poor glycemic control. These findings were only
slightly attenuated by adjustment for a selected set of demo-
graphic and clinical confounders and did not change after
accounting for within-physician and within-facility clustering.
Poor glycemic control is a primary driver of diabetes-
associated microvascular disease.
22 The 11% absolute differ-
ence in the proportion of patients with poor glycemic control
between LEP-discordant and LEP-concordant patients that we
report is clinically meaningful and concerning. The 6% absolute
difference in poor glycemic control between English-speaking
Latinos andwhites, while smaller, andnota novel finding,
23,24 is
also concerning and underscores the need to improve glycemic
control among Latinos irrespective of English language ability.
Language barriers in health care have been associated with
decreased patient satisfaction with care, increased problems
with medication comprehension
19, and decreased receipt of
health services, even in insured patient populations.
25,26 Access
to professional interpreters can improve these outcomes;
27–30
however, emerging evidence suggests that interpreters may be
underutilized even when available, with physicians opting to use
their own limited second language skills or family members as
interpreters.
31–34 W h i l ei n t e r p r e t e r sa r ea v a i l a b l ea ts t u d y
clinical sites, we have no measures of their use.
Table 2. Association of Ethnicity, English Proficiency, and Physician Language Concordance with Poor Glycemic Control (A1c>9%) Among
Insured Patients with Diabetes in GEE Models Accounting for Clustering by Physician and Health Facility
Odds ratio (95% CI) p value LS means predicted probabilities (95% CI)
Unadjusted Whites 1.00 <0.001 9.81 (8.7–11.1)
English Latinos 2.00 (1.72–2.33) 17.9 (16.3–19.5)
English Latinos 1.00 0.04 17.8 (16.2–19.4)
LEP Latinos 1.24 (1.01–1.52) 21.1 (17.9–24.7)
English Latinos 1.00 0.58 17.9 (16.4–19.6)
LEP-Concordant 0.87 (0.53–1.43) 15.9 (10.5–23.4)
English Latinos 1.00 0.03 17.8 (16.3–19.5)
LEP-Discordant 1.76 (1.06–2.93) 27.7 (18.5–39.1)
English Latinos 1.00 0.21 17.9 (16.4–19.5)
LEP-Missing 1.23 (0.89–1.71) 21.2 (16.3–27.1)
LEP-Concordant 1.00 0.003 12.7 (8.6–18.4)
LEP-Discordant 2.21 (1.30–3.76) 24.4 (16.9–33. 9)
Adjusted
a English Latinos 1.00 0.66 16.4 (14.8–18.1)
LEP-Concordant 0.89 (0.53–1.49) 14.9 (9.5–22.5)
English Latinos 1.00 0.03 16.4 (14.9–18.2)
LEP-Discordant 1.76 (1.04–2.97) 25.7 (16.8–37.2)
English Latinos 1.00 0.13 16.4 (14.9–18.1)
LEP-Missing 1.29 (0.93–1.78) 20.2 (15.4–26.0)
LEP-Concordant 1.00 0.04 11.8 (7.3–18.4)
LEP-Discordant 1.98 (1.03–3.80) 20.9 (13.0–31.9)
Abbreviations: English Latinos: English-speaking Latinos; LEP: limited English proficient; LEP-concordant: LEP with language-concordant physician; LEP-
Discordant: LEP with language-discordant physician; LEP-Missing: LEP missing physician language data; LS Means: least squares means
aAdjusted for age, sex, comorbidity index, time since diabetes diagnosis, and continuous pharmacy benefits
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dant care yields better outcomes.
18,26,29,35,36 While the mech-
anism of the observed association between language
concordance and improved glycemic control remains to be
elucidated, it is reasonable to hypothesize that language-
concordant physicians, compared to physicians dependent on
interpreters, may be better able to elicit patient concerns,
37,38
explain diabetes self-management,
19 persuade patients to use
insulin,
39 or recognize and treat the depression common
among patients with diabetes.
40 Physicians using interpreters
have reported difficulties eliciting symptoms, explaining treat-
ments, and eliciting treatment preferences.
38 A recent DIS-
TANCE study using data from Asian as well as Latino patients
with LEP found that reports of communication competence
and trust in their physician were higher when the physician
was language concordant.
41
Our results should be contrasted with a recent, large study
of patients with diabetes cared for in managed care settings
that reported no difference in glycemic control by the preferred
language of Latino patients.
42 In that study, the majority of
Spanish-speaking patients were cared for by Spanish-speak-
ing physicians. Our finding of no differences in glycemic
control between LEP-concordant vs English-speaking Latino
patients is consistent with the previous study’sl a c ko f
difference given their high prevalence of language-concordant
physicians. Our use of poor glycemic control as our main
outcome measure also differs from other studies. Poor glyce-
mic control may be a more clinically relevant and sensitive
outcome than mean glycemic control.
43
The study has several limitations. First, while our results
may not be generalizable to the very poor or very wealthy, we
found that income and education did not impact our models;
however, differences between Latinos and whites may be
conservative in so far as Latinos within Kaiser generally do
not have medication and health care access barriers to
glycemic control. Second, while survey participants may differ
from non-respondents, we found few differences based on
clinical data and census-based socioeconomic data, which
were available for all members of the cohort.
16 Third, most
Latinos in the DISTANCE registry are of Mexican ancestry; the
association between LEP and poor glycemic control may be
different among Latinos of other nationalities.
44,45 Fourth, we
are unable to distinguish language barriers from cultural
barriers to care. Fifth, we used patient report of physician
language fluency to determine concordance and have no
independent measure of physician fluency or use of interpreter
services. Sixth, LEP patients with language-concordant physi-
cians may differ from those with discordant physicians in ways
our data do not capture, and these unmeasured differences
may contribute to the observed differences in glycemic control.
Seventh, while we used a single measure of glycemic control,
studies suggest that a single glycemic value can predict
microsvascular events
46 and that exposure to poor control
can impart a lasting “legacy effect” on microvascular and
macrovascular events years after glycemic control equalizes
between groups.
47
This study also has several strengths. We examined glyce-
mic control for Latino patients with uniform access to prepaid
health care, and the associations we observe among patient
language, physician language concordance, and glycemic
control are not confounded by differences in health care
coverage. In addition, KPNC study sites comply with federal
language access services statutes and offer high-quality inter-
preter services to their patients. Among health plans in
California, Kaiser Permanente has the lowest rate of patient-
reported problems with access and quality of care for patients
with LEP.
48 Differences in glycemic control between language-
concordant and language-discordant interactions may be even
greater at health care facilities with more limited availability of
interpreter services. Finally, we had access to patient self-
report of English language proficiency, the current standard in
determining LEP status.
49
Our study has several implications. First, it confirms that
without assurance of language-concordant providers, LEP
should be considered a risk factor for less effective health
care, even in a context of access to qualified interpreters.
Currently, most quality improvement efforts do not place
language on par with race, ethnicity, or socioeconomic data.
This study and others suggest that LEP status should be
included in quality reporting, as important heterogeneity in
Latino populations is obscured when only ethnicity is exam-
ined.
48 Second, our study suggests that language-concordant
care may make it easier to navigate the myriad issues thought
to influence ethnic disparities in glycemic control generally,
50
and glycemic control among Latinos patients with LEP more
specifically, including cultural attitudes toward diabetes,
51
diabetes medications,
52,53 prevention,
54 and diet,
55,56 as well
as acculturation,
57 limited health literacy,
58 and high rates of
depression.
59 While this observational study cannot provide
evidence for causality, health plans should consider systemat-
ically offering the choice of language-concordant primary care
physicians to patients with diabetes and LEP. The widespread
distribution of patients with LEP throughout the country
already renders increasing the linguistic capacity of the
current physician workforce a priority.
31,60
CONCLUSION
In the 2000 census, 8.1% of the US population, 18 million
adults, most of them Latinos, reported speaking English less
than very well.
61 Latinos with LEP currently constitute nearly
half of the California Latino population with diabetes.
62
Patients with LEP and diabetes—an illness that demands
substantial knowledge, self-management, and ongoing inter-
action with the medical system—may be particularly vulnera-
ble to the challenges posed by inadequate communication. Our
study finds that LEP is a contributor to ethnic disparities and a
significant and independent predictor of poor glycemic control
among Latinos with diabetes, an association not observed
when care is provided by language-concordant physicians.
Future research should determine if strategies to link Spanish-
speaking patients with Spanish-speaking physicians reduce
language and ethnic disparities in glycemic control.
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